deltatrials
Terminated OBSERVATIONAL NCT04717453

Study to Characterize Rate of Ureagenesis in Patients With Ornithine Transcarbamylase (OTC) Deficiency

A Study to Characterize Rate of Ureagenesis Utilizing Oral [1-13C] Sodium Acetate in the Spectrum of Severity of Patients With Ornithine Transcarbamylase (OTC) Deficiency

Sponsor: Ultragenyx Pharmaceutical Inc

Conditions Ornithine Transcarbamylase Deficiency
Interventions No Intervention
Updated 13 times since 2021 Last updated: Feb 2, 2022 Started: Oct 6, 2020 Primary completion: Dec 15, 2021 Completion: Dec 15, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor's Decision

Other terminated trials from Ultragenyx Pharmaceutical Inc

More terminations from Ultragenyx Pharmaceutical Inc

A observational or N/A phase clinical study on Ornithine Transcarbamylase Deficiency, this trial is terminated or withdrawn. The trial is conducted by Ultragenyx Pharmaceutical Inc and has accumulated 13 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Mar 2022 · 59 days · monthly snapshot~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated

  3. Mar 2022 — Jul 2024 [monthly]

    Terminated

    Status: Active Not Recruiting → Terminated

  4. Jan 2022 — Mar 2022 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  5. Dec 2021 — Jan 2022 [monthly]

    Recruiting

▶ Show 8 earlier versions

  1. Nov 2021 — Dec 2021 [monthly]

    Recruiting

  2. Oct 2021 — Nov 2021 [monthly]

    Recruiting

  3. Sep 2021 — Oct 2021 [monthly]

    Recruiting

  4. Jun 2021 — Sep 2021 [monthly]

    Recruiting

  5. May 2021 — Jun 2021 [monthly]

    Recruiting

  6. Apr 2021 — May 2021 [monthly]

    Recruiting

  7. Mar 2021 — Apr 2021 [monthly]

    Recruiting

  8. Feb 2021 — Mar 2021 [monthly]

    Recruiting

    First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ultragenyx Pharmaceutical Inc
Data source: Ultragenyx Pharmaceutical Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations